Epidermal Growth Factor Receptor Gene Mutation trials recruiting in New Jersey

Fewer than 3 recruiting trials found.

All Epidermal Growth Factor Receptor Gene Mutation trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
  NCT07462377 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: East Brunswick
• Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
  NCT06538038 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Moorestown, Morristown, New Brunswick, Paramus